Author: BusinessWire

– Company advances NT-0167 as first development candidate from a broad platform of NLRP3 inflammasome inhibitors – – Appoints Don…

Researchers can now access and purchase nearly two million off-the-shelf antibodies, ELISA Kits, proteins and related reagents through Scientist.com’s award-winning…

DUBLIN–(BUSINESS WIRE)–The “Global Central Nervous System Therapeutic Market: Analysis By Disease, By Region, By Country (2019 Edition): Opportunities and Forecast…

– Financing to Advance Lead Development Program, INZ-701, through Clinical Proof of Concept in Two Indications – – Company Expands…

Dr. Reardon to lead strategic development of Ribometrix platform for novel RNA drug discovery Appointment of two vice presidents to…

HALIFAX, Nova Scotia–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24IMV&src=ctag" target="_blank"gt;$IMVlt;/agt; lt;a href="https://twitter.com/hashtag/AntibioticDeveloper?src=hash" target="_blank"gt;#AntibioticDeveloperlt;/agt;–Pharmaceutical company Appili Therapeutics Inc. (“Appili” or the “Company”) announced today that…

Acceptance for late breaking oral presentation underscores the oncology community’s interest in Namodenoson as a potential treatment for liver cancer…

DUBLIN–(BUSINESS WIRE)–The “Breakthroughs in Non-Alcoholic Steatohepatitis Management” report has been added to ResearchAndMarkets.com’s offering. Non-Alcoholic Steatohepatitis or NASH is a…

Financing to drive leadership in AAV vector-delivered one-time therapies for major chronic pet health conditions Company supported by leading life…

LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated an additional…